95 related articles for article (PubMed ID: 16583211)
1. Identification and functional perspective of a novel HLA-A allele: A*0279.
Liu F; Wang S; Ye Y; Zhang H; Zhang Y; Chen W
Immunogenetics; 2006 Jun; 58(5-6):339-46. PubMed ID: 16583211
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
[TBL] [Abstract][Full Text] [Related]
4. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes.
Niu L; Cheng H; Zhang S; Tan S; Zhang Y; Qi J; Liu J; Gao GF
Mol Immunol; 2013 Oct; 55(3-4):381-92. PubMed ID: 23566939
[TBL] [Abstract][Full Text] [Related]
6. Two novel alleles HLA-A*02:433 and HLA-A*02:434 identified in Saudi bone marrow donors using sequence-based typing.
Fakhoury HA; Jawdat D; Alaskar AS; Al Jumah M; Cereb N; Hajeer AH
Int J Immunogenet; 2014 Aug; 41(4):338-9. PubMed ID: 24919814
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer.
Liu W; Zhai M; Wu Z; Qi Y; Wu Y; Dai C; Sun M; Li L; Gao Y
Amino Acids; 2012 Jun; 42(6):2257-65. PubMed ID: 21710262
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel HLA-A allele, HLA-A*01:195, in a UAE national.
Abdrabou W; Witzel II; Paduch A; Tay G; Alsafar H
Hum Immunol; 2016 Jul; 77(7):605-8. PubMed ID: 27184862
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel HLA-A allele, A*11:60, in a Taiwanese family.
Yang KL; Lee SK; Lin CC; Jiang S; Chiu HM; Lin S; Chen YC; Jian YF; Chen MJ; Shyr MH; Lin CL; Lin PY
Int J Immunogenet; 2011 Apr; 38(2):167-9. PubMed ID: 21362146
[TBL] [Abstract][Full Text] [Related]
10. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
[TBL] [Abstract][Full Text] [Related]
11. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
[TBL] [Abstract][Full Text] [Related]
12. Class I cross-restricted T cells reveal low responder allele due to processing of viral antigen.
Bodmer HC; Gotch FM; McMichael AJ
Nature; 1989 Feb; 337(6208):653-5. PubMed ID: 2537466
[TBL] [Abstract][Full Text] [Related]
13. [Identification of a new human leukocyte antigen A allele, HLA-A*3020].
Li X; Zhang X; Chen Y; Zhang K; Liu X; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):96-9. PubMed ID: 20140878
[TBL] [Abstract][Full Text] [Related]
14. HLA-A*2634, a new allele identified by sequence-based typing in the Korean population.
Kwon OJ; Hong SA; Oh JW; Nah SY; Jeong SM
Tissue Antigens; 2007 Jun; 69(6):613-5. PubMed ID: 17498275
[TBL] [Abstract][Full Text] [Related]
15. [Identification of a novel HLA allele A*29:49 using sequence based typing].
Chen Y; Li Y; Xu X; Zhai P; Zhang Y; Zhu C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):841-843. PubMed ID: 27984618
[TBL] [Abstract][Full Text] [Related]
16. The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206.
Torikai H; Akatsuka Y; Miyauchi H; Terakura S; Onizuka M; Tsujimura K; Miyamura K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Bone Marrow Transplant; 2007 Jul; 40(2):165-74. PubMed ID: 17530010
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel HLA-A*26 allele, HLA-A*2632, by sequence-based typing in the Korean population.
Kwon OJ; Lee JS; Oh JW; Nah SY; Jeong SM
Tissue Antigens; 2007 Jun; 69(6):612-3. PubMed ID: 17498274
[TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule.
Hogan KT; Clayberger C; Le AX; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1988 Dec; 141(11):4005-11. PubMed ID: 2460555
[TBL] [Abstract][Full Text] [Related]
20. HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.
Chauvin JM; Larrieu P; Sarrabayrouse G; Prévost-Blondel A; Lengagne R; Desfrançois J; Labarrière N; Jotereau F
J Immunol; 2012 Mar; 188(5):2102-10. PubMed ID: 22291187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
